Summary

Overview
The global biomedical textiles market reached US$ 17.8 billion in 2023 and is expected to reach US$ 28.8 billion by 2031 growing with a CAGR of 6.2% during the forecast period 2024-2031.
Biomedical textiles are fiber-based medical devices that can be implanted in patients to restore tissue properties, provide mechanical support, as well as facilitate the healing process for a variety of indications. Textile-based implantable medical devices include but are not limited to sutures, meshes, vascular grafts, and heart valves.
Biomedical textiles may be created from synthetic or natural sources and may be non-resorbable or resorbable based on the medical device’s intended use. Biomedical textiles may be constructed by four main processing methods knitting, weaving, braiding, and non-woven methods.
The biomedical textiles market involves the production and use of textile products designed specifically for medical and biological applications. These textiles are used in various medical fields, including wound care, implants, surgical sutures, and healthcare fabrics. They are engineered to interact with biological systems and are designed for performance characteristics such as biocompatibility, antimicrobial properties, durability, and the ability to promote healing and tissue regeneration.
Market Dynamics: Drivers
Growing aging population & prevalence of chronic diseases and rising number of surgical procedures
The demand for the global biomedical textiles market is driven by multiple factors. The growing aging population & the prevalence of chronic diseases and the rising number of surgical procedures are also contributing to the expansion of the market.
The growing aging population globally is driving the demand for healthcare services and products. As the elderly population increases, there is a greater need for wound care, orthopedic support, and other biomedical textiles that cater to age-related conditions. In addition, the prevalence of chronic diseases, such as diabetes and cardiovascular diseases, further fuels the demand for biomedical textiles for wound management and treatment.
Moreover, key players' strategies such as partnerships & collaborations would drive this market growth. For instance, in April 2022, Integer Holdings Corporation announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical. By using this acquisition consistent with our strategy, the combination with Aran further increases Integer’s ability to offer complete solutions for complex delivery and therapeutic devices in high-growth cardiovascular markets such as structural heart, neurovascular, peripheral vascular, and endovascular as well as general surgery.
The increasing number of surgeries and the demand for high-quality wound dressing material are expected to drive the biomedical textiles market. With the use of biomedical textiles, damaged tissues or organs can be treated, which is a result of advanced medical inventions related to biomedical textiles.
Restraints
Factors such as high R&D investments, shortages of raw materials, lack of awareness among individuals, and regulatory challenges are expected to hamper the market.
For more details on this report - Request for Sample
Segment Analysis
The global biomedical textiles market is segmented based on fiber, fabric, application, and region.
The non-biodegradable fiber segment accounted for approximately 56.6% of the global biomedical textiles market share
The non-biodegradable fiber segment is expected to hold the largest market share over the forecast period. These are the fibers that are not degraded by biological conditions for a long time and are mostly used for external purposes. These include polytetrafluoroethylene (PTFE), polyester, polypropylene, carbon, and others. Non-biodegradable fibers are used for applications where long-lasting performance is required, such as in surgical sutures, wound dressings, and implantable devices.
These sutures provide the necessary support to hold tissues together during the healing process, making them indispensable in surgical procedures. Their resistance to degradation ensures that they maintain structural integrity in medical applications, which is critical for patient safety and efficacy of treatment.
In addition, key players in the industry's innovative developments propel this segment's growth. For instance, in August 2022, The RGE-NTU SusTex project aims to accelerate innovation in textile recycling and translate research outcomes into practical solutions that can be deployed in urban settings like Singapore. Researchers in the S$6m joint research center will look into areas such as next-generation eco-friendly and sustainable textiles and refabricating textile waste into fiber. The aim is to study the chemistry of various textile materials and determine the optimal processes and techniques required to start a circular textile economy.
Geographical Analysis
North America accounted for approximately 45.7% of the global biomedical textiles market share
North America region is expected to hold the largest market share over the forecast period increasing the prevalence of chronic diseases, advancements in healthcare technology, and well-established healthcare infrastructure help to drive this market growth.
According to the National Institutes of Health, in June 2023, a significant portion of the U.S. population suffered from conditions requiring advanced medical interventions, which in turn drives the demand for biomedical textiles. For instance, the growing number of surgeries related to obesity and cardiovascular issues necessitates the use of specialized textiles for surgical applications.
Moreover, a major number of key players' presence and key developments in biomedical textiles propel this market growth in this region. For instance, in March 2024, Integra LifeSciences Holdings Corporation announced that MicroMatrix Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.
Also, in October 2022, Cortland Biomedical unveiled new capabilities for creating textile structures incorporating radiopaque fibers. Incorporating radiopaque fibers into diagnostic and interventional medical devices enables the devices to become visible under fluoroscopy.
Market Segmentation
By Fiber
• Non-biodegradable Fiber
• Biodegradable Fiber
• Others
By Fabric
• Woven
• Non-woven
• Others
By Application
• Implantable
• Non-implantable
• Surgical Sutures
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o The rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the biomedical textiles market include Bally Ribbon Mills, Medical Murray, Indorama Corporation, Confluent Medical Technologies, ARAN BIOMEDICAL TEORANTA, Poly-Med Incorporated, CORTLAND BIOMEDICAL, Secant Group, Integer Holdings Corporation and Swicofil AG among others.
Key Developments
 In June 2023, AccYouRate launched a smart T-shirt capable of providing real-time online monitoring of the body’s vital signals. The 100% textile e-shirt measures ECG (including heart rate), breathing frequency and depth, body temperature, accelerometer, GPS, and body position, which enables fall alerts.
 In February 2021, Ahlstrom-Munksjö launched a new product portfolio, which consists of a full suite of fabrics for medical and civil use face masks, including biodegradable and compostable materials such as PLA and cellulosic. The TenderGuard product portfolio consists of exceptionally soft, comfortable, and protective fabrics including TenderGuard BioBased and BioFilter fabrics, which are designed for civil use and source control for infectious diseases.
Why Purchase the Report?
• To visualize the global biomedical textiles market segmentation based on fiber, fabric, application, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the biomedical textiles market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in Excel consisting of key products of all the major players.
The global biomedical textiles market report would provide approximately 62 tables, 53 figures, and 183 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

Table of Contents
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Fiber
3.2. Snippet by Fabric
3.3. Snippet by Application
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Aging Population & Prevalence of Chronic Diseases and Rising Number of Surgical Procedures
4.1.1.2. Growing Need for High-Quality Wound Dressing Material
4.1.2. Restraints
4.1.2.1. High R&D Investments
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Fiber
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
6.1.2. Market Attractiveness Index, By Fiber
6.2. Non-biodegradable Fiber *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Biodegradable Fiber
6.4. Others
7. By Fabric
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
7.1.2. Market Attractiveness Index, By Fabric
7.2. Woven*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Non-woven
7.4. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Market Attractiveness Index, By Application
8.2. Implantable *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Non-implantable
8.4. Surgical Sutures
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Spain
9.3.6.5. Italy
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Bally Ribbon Mills *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Medical Murray
11.3. Indorama Corporation
11.4. Confluent Medical Technologies
11.5. ARAN BIOMEDICAL TEORANTA
11.6. Poly-Med Incorporated
11.7. CORTLAND BIOMEDICAL
11.8. Secant Group
11.9. Integer Holdings Corporation
11.10. Swicofil AG
LIST NOT EXHAUSTIVE
12. Appendix
12.1. About Us and Services
12.2. Contact Us